发明人刘建华,郑宇鹏,沈红梅. "一种伊马替尼杂质35的合成方法" [P]. 中国发明专利, 专利号 CN 109619100 A, 授权公告日 2015-07-16.
发明人郑宇鹏,张德明,沈红梅. "Method for the Synthesis of Imatinib Impurity 35" [P]. 中国发明专利, 专利号 CN 114158855 A, 授权公告日 2021-05-26.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 伊马替尼杂质35 in Pharmaceutical Formulations". Food Chem., 2011, 1764, (4), 4140-4169.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊马替尼杂质35 as an Impurity". J. Nat. Prod., 2023, 1222, (1), 2536-2557.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Imatinib Impurity 35 Using HRMS and NMR". Anal. Chim. Acta, 2025, 912, (6), 8540-8558.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 伊马替尼杂质35 Profile in Drug Substances According to ICH Guidelines". Talanta, 2011, 1306, (10), 6609-6629.